3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Osteochondroma
1
Exostoses, Multiple Hereditary
1
Interventions
Palovarotene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Exostoses, Multiple Hereditary
×
Palovarotene
×
Clear all
NCT03442985
2022-08-01
MO-Ped
Ipsen
Phase 2
Terminated
193 enrolled
20 charts